In support of this observation, colchicine, the first-line treatment for FMF, still blocks Pyrin activation in macrophages but not monocytes, providing an explanation for how it prevents FMF in the absence of Pyrin inhibition in monocytes. This evidence concerns the gene MEFV and familial Mediterranean fever.